Clozapine decreases smoking in patients with chronic schizophrenia. 1995

J McEvoy, and O Freudenreich, and M McGee, and C VanderZwaag, and E Levin, and J Rose
Department of Psychiatry, Duke University Medical Center, NC, USA.

UI MeSH Term Description Entries
D008297 Male Males
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D012565 Schizophrenic Psychology Study of mental processes and behavior of schizophrenics. Psychology, Schizophrenic

Related Publications

J McEvoy, and O Freudenreich, and M McGee, and C VanderZwaag, and E Levin, and J Rose
December 1998, Journal of clinical psychopharmacology,
J McEvoy, and O Freudenreich, and M McGee, and C VanderZwaag, and E Levin, and J Rose
May 2000, Psychiatric services (Washington, D.C.),
J McEvoy, and O Freudenreich, and M McGee, and C VanderZwaag, and E Levin, and J Rose
January 2015, International psychogeriatrics,
J McEvoy, and O Freudenreich, and M McGee, and C VanderZwaag, and E Levin, and J Rose
January 1999, International journal of psychiatry in clinical practice,
J McEvoy, and O Freudenreich, and M McGee, and C VanderZwaag, and E Levin, and J Rose
December 1998, Therapeutic drug monitoring,
J McEvoy, and O Freudenreich, and M McGee, and C VanderZwaag, and E Levin, and J Rose
September 2002, Pharmacopsychiatry,
J McEvoy, and O Freudenreich, and M McGee, and C VanderZwaag, and E Levin, and J Rose
July 1999, Journal of clinical pharmacology,
J McEvoy, and O Freudenreich, and M McGee, and C VanderZwaag, and E Levin, and J Rose
August 2011, Progress in neuro-psychopharmacology & biological psychiatry,
J McEvoy, and O Freudenreich, and M McGee, and C VanderZwaag, and E Levin, and J Rose
October 1986, The British journal of psychiatry : the journal of mental science,
J McEvoy, and O Freudenreich, and M McGee, and C VanderZwaag, and E Levin, and J Rose
June 2009, Therapeutic drug monitoring,
Copied contents to your clipboard!